Epstein-Barr virus reprograms autoreactive B cells, possibly contributing to systemic lupus erythematosus, with infected B cells in patients showing high antigen-presenting capabilities.

Cancer immunology research has increasingly focused on the complex interactions between oncogenic drivers, such as KRAS mutations, and the tumor ...

The Donor Selection & Cell Source Summit, hosted by Hanson Wade, brings together leaders from industry and academia to address critical bottlenecks in donor screening, cell sourcing, and process ...

The field of tissue-immune interactions has undergone significant transformation as emerging evidence demonstrates the centrality of local microenvironments ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat ...

If you live in the United States, odds are high that a tiny passenger rides in your blood. By adulthood, more than 94 percent ...

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsDavid Dodd - Chairman, President & CEOMark Reynolds ...

Today, Xencor management also became aware that an investment bank published takeaways from the abstract accepted for presentation at the conference, which is not publicly available via the conference ...